This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hall, M. N. Articles by Ma, J. Search for Related Content PubMed PubMed Citation Articles by Hall, M. N. Articles by Ma, J.

Blood Levels of Long-Chain Polyunsaturated Fatty Acids, Aspirin, and the Risk of Colorectal Cancer

Departments of ¹ Nutrition and ² Epidemiology, Harvard School of Public Health; ³ Channing Laboratory and ⁴ Division of Preventive Medicine, Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts

Requests for reprints: Jing Ma, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Room 336, Harvard Medical School, 181 Longwood Ave, Boston, MA 02115. Phone: 617-525-2708; Fax: 617-525-2008. E-mail: jing.ma{at}channing.harvard.edu

Background: N-3 fatty acids may decrease risk of colorectal cancer by inhibiting the cyclooxygenase-2 enzyme and production of proinflammatory eicosanoids derived from arachidonic acid (20:4n-6). Aspirin also inhibits the cyclooxygenase-2 enzyme and may share with n-3 fatty acids a potential mechanism to decrease the risk of colorectal cancer.

Methods: We conducted a nested case-control analysis using blood samples collected from the Physicians' Health Study participants in 1982 to 1984. N-3 and n-6 fatty acid levels were measured using gas-liquid chromatography for 178 men who developed colorectal cancer through December 31, 1995 and 282 age- and smoking-matched controls. We used conditional logistic regression to examine associations. All statistical tests were two-sided.

Results: Total long-chain n-3 fatty acids were nonsignificantly inversely associated with colorectal cancer risk [relative risk (RR) for highest versus lowest quartile, 0.60; 95% confidence interval (95% CI), 0.32 to 1.11; P_trend = 0.10], after adjustment for possible confounders. We observed potential interaction between randomized aspirin assignment and long-chain n-3 fatty acid levels (P_interaction = 0.04). Among men not on aspirin, RRs (95% CI) for increasing quartiles of long-chain n-3 fatty acids were 1.00 (reference), 0.60 (0.28-1.28), 0.51 (0.22-1.17), and 0.34 (0.15-0.82), P_trend = 0.006. For participants taking aspirin, there was no additional benefit of increasing n-3 fatty acid levels. The RR (95% CI) for the highest versus lowest quartile of n-6 fatty acids was 0.64 (0.35-1.17).

Conclusions: Blood levels of long-chain n-3 fatty acids were associated with decreased risk of colorectal cancer among men not using aspirin. N-6 fatty acids were nonsignificantly inversely associated with colorectal cancer risk. (Cancer Epidemiol Biomarkers Prev 2007;16(2):314–21)

This article has been cited by other articles:

				M. N. Hall, J. E. Chavarro, I-M. Lee, W. C. Willett, and J. Ma A 22-year Prospective Study of Fish, n-3 Fatty Acid Intake, and Colorectal Cancer Risk in Men Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1136 - 1143. [Abstract] [Full Text] [PDF]

				A. Geelen, J. M. Schouten, C. Kamphuis, B. E. Stam, J. Burema, J. M. S. Renkema, E.-J. Bakker, P. van't Veer, and E. Kampman Fish Consumption, n-3 Fatty Acids, and Colorectal Cancer: A Meta-Analysis of Prospective Cohort Studies Am. J. Epidemiol., November 15, 2007; 166(10): 1116 - 1125. [Abstract] [Full Text] [PDF]